Cited by 413Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsVasculitis and related conditions

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

Galli, Monica, Luciani, Davide, Bertolini, Guido, Barbui, Tiziano·2003·Blood

DOI 10.1182/blood-2002-11-3334

Open this paper in CoChat — free account

Abstract

The association of antiphospholipid antibodies with thrombosis and obstetric events defines the antiphospholipid syndrome. A recent systematic review of the literature showed lupus anticoagulants to be risk factors of thrombosis, independent of the type and site of the event, the presence of

Integrity signals

Registry

Crossref · 10.1182/blood-2002-11-3334

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., Baets, M. H. D., & Vriesman, P. J. C. V. B. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,266
Self-citation
Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.
Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164
Criteria for the Diagnosis of Lupus Anticoagulants: An Update: On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH
Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 972
Self-citation
The “Primary” Antiphospholipid Syndrome
Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease
Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., & Koike, T. (1990) · The Lancet · doi:10.1016/0140-6736(90)91697-9 · Cited by 718

Show all 72 references

Research works printed but not linked: 2

Galli M, Bevers EM, Barbui T. Immunologic properties and anticoagulant activity of antiphospholipid antibodies. In: Levine SR, Brey RL, eds. Clinical Approach to Antiphospolipid Antibodies. Boston, MA: Butterworth; 2000: 19-31.
Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost.1995;74: 1120-1125. · DOI

Sorted by citations

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Antiphospholipid syndrome
Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 875
Guidelines on the investigation and management of antiphospholipid syndrome
Keeling, D., Mackie, I., Moore, G. W., Greer, I. A., Greaves, M., & British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09037.x · Cited by 740
Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome
PENGO, V., RUFFATTI, A., LEGNANI, C., GRESELE, P., BARCELLONA, D., ERBA, N., TESTA, S., MARONGIU, F., BISON, E., DENAS, G., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03674.x · Cited by 632
Pathogenesis of antiphospholipid syndrome: understanding the antibodies
Meroni, P. L., Borghi, M. O., Raschi, E., & Tedesco, F. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.52 · Cited by 620
Deep vein thrombosis
Kyrle, P. A., & Eichinger, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71880-8 · Cited by 625
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task Force at the 13th International Congress on antiphospholipid antibodies
Ruiz-Irastorza, G., Cuadrado, M., Ruiz-Arruza, I., Brey, R., Crowther, M., Derksen, R., Erkan, D., Krilis, S., Machin, S., Pengo, V, et al. (2011) · Lupus · doi:10.1177/0961203310395803 · Cited by 506
Management of Antiphospholipid Antibody Syndrome
Lim, W., Crowther, M. A., & Eikelboom, J. W. (2006) · JAMA · doi:10.1001/jama.295.9.1050 · Cited by 441
Antiphospholipid syndrome
Schreiber, K. I., Sciascia, S., de Groot, P. G., Devreese, K. M. J., Jacobsen, S., Ruiz‐Irastorza, G., Salmon, J. E., Shoenfeld, Y., Shovman, O., & Hunt, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.103 · Cited by 445
Antibody profiles for the diagnosis of antiphospholipid syndrome
Biasiolo, A., Pegoraro, C., Cucchini, U., Noventa, F., Iliceto, S., & Pengo, V. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0839 · Cited by 318
The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study
DE LAAT, B., PENGO, V., PABINGER, I., MUSIAL, J., VOSKUYL, A. E., BULTINK, I. E. M., RUFFATTI, A., ROZMAN, B., KVEDER, T., DE MOERLOOSE, P., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03588.x · Cited by 291
Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug
Rand, J. H., Wu, X.-X., Quinn, A. S., Ashton, A. W., Chen, P. P., Hathcock, J. J., Andree, H. A. M., & Taatjes, D. J. (2010) · Blood · doi:10.1182/blood-2009-04-213520 · Cited by 253
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome
Sciascia, S., Sanna, G., Murru, V., Roccatello, D., Khamashta, M. A., & Bertolaccini, M. L. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0509 · Cited by 253
β2-glycoprotein I–dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome
de Laat, H. B., Derksen, R. H. W. M., Urbanus, R. T., Roest, M., & de Groot, P. G. (2004) · Blood · doi:10.1182/blood-2004-03-1107 · Cited by 219
Current concepts on the pathogenesis of the antiphospholipid syndrome
Giannakopoulos, B., Passam, F. H., Rahgozar, S., & Krilis, S. A. (2006) · Blood · doi:10.1182/blood-2006-04-001206 · Cited by 217
Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies
Zhang, J., & McCrae, K. R. (2004) · Blood · doi:10.1182/blood-2004-05-1708 · Cited by 212
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis
DE GROOT, P. G., LUTTERS, B., DERKSEN, R. H. W. M., LISMAN, T., MEIJERS, J. C. M., & ROSENDAAL, F. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01485.x · Cited by 205
The antiphospholipid syndrome in patients with systemic lupus erythematosus
Pons‐Estel, G., Andréoli, L., Scanzi, F., Cervera, R., & Tincani, A. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.10.004 · Cited by 208
Antiphospholipid antibodies promote leukocyte–endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2
Ramesh, S., Morrell, C. N., Tarango, C., Thomas, G. D., Yuhanna, I. S., Girardi, G., Herz, J., Urbanus, R. T., de Groot, P. G., Thorpe, P. E., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39828 · Cited by 195
How we diagnose the antiphospholipid syndrome
Giannakopoulos, B., Passam, F. H., Ioannou, Y., & Krilis, S. A. (2008) · Blood · doi:10.1182/blood-2007-12-129627 · Cited by 187
Prevention and Treatment of Venous Thromboembolism
Nicolaides, A. N., Fareed, J., Kakkar, A. K., Comerota, A. J., Goldhaber, S. Z., Hull, R. D., Myers, K. A., Samama, M. M., Fletcher, J., Kalodiki, E., et al. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612474840 · Cited by 187
The geoepidemiology of the antiphospholipid antibody syndrome
Biggioggero, M., & Meroni, P. L. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.11.013 · Cited by 185
Antiphospholipid Syndrome
Corban, M., Duarte‐García, A., McBane, R. D., Matteson, E. L., Lerman, L. O., & Lerman, A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.058 · Cited by 186
Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis
Reynaud, Q., Lega, J.-C., Mismetti, P., Chapelle, C., Wahl, D., Cathébras, P., & Laporte, S. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.11.004 · Cited by 179
‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010
Pierangeli, S., de Groot, P. G., Dlott, J. S., Favaloro, E. J., Harris, E., Lakos, G., Ortel, T. L., Meroni, P. L., Otomo, K., Pengo, V., et al. (2011) · Lupus · doi:10.1177/0961203310395055 · Cited by 179
Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome
Cesarman-Maus, G. N., Ríos-Luna, N. P., Deora, A. B., Huang, B., Villa, R., Cravioto, M. D. C., Alarcón-Segovia, D., Sánchez‐Guerrero, J., & Hajjar, K. A. (2006) · Blood · doi:10.1182/blood-2005-07-2636 · Cited by 174
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
Galli, M., Borrelli, G., Jacobsen, E. M., Marfisi, R. M., Finazzi, G., Marchioli, R., Wisloff, F., Marziali, S., Morboeuf, O., & Barbui, T. (2007) · Blood · doi:10.1182/blood-2007-01-066043 · Cited by 170
Self-citation
A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosis
FORASTIERO, R., MARTINUZZO, M., POMBO, G., PUENTE, D., ROSSI, A., CELEBRIN, L., BONACCORSO, S., & AVERSA, L. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01295.x · Cited by 170
The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review
Sciascia, S., Sanna, G., Khamashta, M. A., Cuadrado, M. J., Erkan, D., Andréoli, L., & Bertolaccini, M. L. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205663 · Cited by 162
The potential role of heparin in assisted conception
Nelson, S. M., & Greer, I. A. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn031 · Cited by 161
‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010
Bertolaccini, M. L., Amengual, O., Atsumi, T., Binder, W., de Laat, B., Forastiero, R. R., Kutteh, W. H., Lambert, M., Matsubayashi, H., Murthy, V. L., et al. (2011) · Lupus · doi:10.1177/0961203310397082 · Cited by 148
β2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model
Arad, A., Proulle, V., Furie, R. A., Furie, B. C., & Furie, B. (2011) · Blood · doi:10.1182/blood-2010-08-300715 · Cited by 140
Pathophysiology of the antiphospholipid syndrome
de Groot, P. G., & Derksen, R. H. W. M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01359.x · Cited by 134
Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies
Tincani, A., Allegri, F., Balestrieri, G., Reber, G., Sanmarco, M., Meroni, P. L., & Boffa, M. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.035 · Cited by 128
Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review
Sciascia, S., Bertolaccini, M. L., Roccatello, D., Khamashta, M. A., & Sanna, G. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7406-8 · Cited by 114
Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)
Andrade, R. M., AlarcÃ³n, G. S., González, L., FernÃ¡ndez, M., Apte, M., Vilá, L. M., McGwin, G., & Reveille, J. D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.077594 · Cited by 114
Antiprothrombin antibodies detected in two different assay systems
Atsumi, T., Koike, T., Hughes, G. R. V., Khamashta, M. A., & Bertolaccini, M. L. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-06-0382 · Cited by 113
Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events
Feinbloom, D. B., & Bauer, K. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000181762.31694.da · Cited by 112
Antiphospholipid Syndrome during pregnancy: the state of the art.
Prima, F. A. F. D., Valenti, O., Hyseni, E., Giorgio, E., Faraci, M., Renda, E., Domenico, R. D., & Monte, S. (2011) · PubMed Central · Cited by 111
Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study
Gris, J., Bouvier, S., Molinari, N., Galanaud, J. ‐., Cochery-Nouvellon, É., Mercier, É., Fabbro-Péray, P., Balducchi, J.-P., Marès, P., Quéré, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-381913 · Cited by 108
Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus
Male, C., Foulon, D., Hoogendoorn, H., Vegh, P., Silverman, E., David, M., & Mitchell, L. (2005) · Blood · doi:10.1182/blood-2005-05-2048 · Cited by 106
The annexin A2 system and vascular homeostasis
Flood, E. C., & Hajjar, K. A. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.03.003 · Cited by 103
Antiphospholipid syndrome; its implication in cardiovascular diseases: a review
Koniari, I. C., Siminelakis, S. N., Baikoussis, N. G., Papadopoulos, G., Goudevenos, J. A., & Apostolakis, E. E. (2010) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-5-101 · Cited by 103
Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope
de Laat, B., van Berkel, M., Urbanus, R. T., Siregar, B., de Groot, P. G., Gebbink, M. F. B. G., & Maas, C. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30633 · Cited by 103
Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants
Nakashima, M. O., & Rogers, H. J. (2014) · Blood Research · doi:10.5045/br.2014.49.2.85 · Cited by 103
Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome
Woller, S. C., Stevens, S. M., Kaplan, D. A., Branch, D. W., Aston, V. T., Wilson, E. L., Gallo, H. M., Johnson, E., Rondina, M. T., Lloyd, J. F., et al. (2015) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615615960 · Cited by 100
High titer of anti–phosphatidylserine‐prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa
Kawakami, T., Yamazaki, M., Mizoguchi, M., & Soma, Y. (2007) · Arthritis Care & Research · doi:10.1002/art.23081 · Cited by 93
Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases
Meroni, P. L., Biggioggero, M., Pierangeli, S. S., Sheldon, J., Zegers, I., & Borghi, M. O. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.180 · Cited by 92
Mechanisms of Disease: antiphospholipid antibodies—from clinical association to pathologic mechanism
de Laat, B., Mertens, K., & de Groot, P. G. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0740 · Cited by 90
Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies
Forastiero, R. R., Martinuzzo, M. E., & Larrañaga, G. F. D. (2005) · Lupus · doi:10.1191/0961203305lu2048oa · Cited by 89
The antiphospholipid syndrome and heart valve surgery
Gorki, H., Malinovski, V., & Stanbridge, R. D. L. (2007) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2007.11.004 · Cited by 88
Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria
Litvinova, E., Darnige, L., Kirilovsky, A., Burnel, Y., Luna, G. D., & Dragon‐Durey, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02971 · Cited by 87
Invitation to a debate on the serological criteria that define the antiphospholipid syndrome
GALLI, M., REBER, G., DE MOERLOOSE, P., & DE GROOT, P. G. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02862.x · Cited by 85
Self-citation
The presence of IgG antibodies against β2‐glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant
Rintelen, C., Vormittag, R., Sailer, T., Lehr, S., Quehenberger, P., Rumpold, H., Male, C., & Pabinger, I. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01394.x · Cited by 82
Anti‐prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15‐year longitudinal study
Bizzaro, N., Ghirardello, A., Zampieri, S., Iaccarino, L., Tozzoli, R., Ruffatti, A., Villalta, D., Tonutti, E., & Doria, A. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02532.x · Cited by 81
Laboratory Testing for Lupus Anticoagulants: A Review of Issues Affecting Results
Tripodi, A. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.089524 · Cited by 81
Anti‐beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women
Meroni, P. L., Peyvandi, F., Foco, L., Bernardinelli, L., Fetiveau, R., Mannucci, P. M., & Tincani, A. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02763.x · Cited by 77
Antiphospholipid antibody ELISAs: Survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-β2-Glycoprotein I activity
Pengo, V., Biasiolo, A., Bison, E., Chantarangkul, V., & Tripodi, A. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.07.014 · Cited by 77
Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome
Urbanus, R. T., Derksen, R. H. W. M., & de Groot, P. G. (2007) · Blood Reviews · doi:10.1016/j.blre.2007.09.001 · Cited by 76
Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis
Santos, T. D. S., Ieque, A. L., de Carvalho, H. C., Sell, A. M., Lonardoni, M. V. C., Demarchi, I. G., Neto, Q. A. D. L., & Teixeira, J. J. V. (2017) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2017.09.007 · Cited by 76
Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines
Favaloro, E. J., & Wong, R. C. W. (2014) · Pathology · doi:10.1097/pat.0000000000000142 · Cited by 75
Autoantibodies in Nonautoimmune Individuals during Infections
Berlin, T., Zandman‐Goddard, G., Blank, M., Matthias, T., Pfeiffer, S., Weis, I., Toubi, E., Singh, S., Asherson, R. A., Fraser, A., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1422.061 · Cited by 74
β2-Glycoprotein I, the playmaker of the antiphospholipid syndrome
de Laat, H. B., Derksen, R. H. W. M., & de Groot, P. G. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.02.012 · Cited by 70
Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review
Radin, M., Cecchi, I., Roccatello, D., Meroni, P. L., & Sciascia, S. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1603936 · Cited by 70
Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant
Sciascia, S., Murru, V., Garcia-Fernandez, C., Sanna, G., Khamashta, M., & Bertolaccini, M. L. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-07-0527 · Cited by 67
Antiphosphatidylserine/Prothrombin Antibodies (aPS/PT) as Potential Markers of Antiphospholipid Syndrome
Vlagea, A. D., Gil, A., Cuesta‐Corral, M., Arribas, F., Diez, J., Lavilla, P., & Pascual‐Salcedo, D. (2012) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612437578 · Cited by 66
Antiphospholipid antibodies in lymphoma: prevalence and clinical significance
Pusterla, S., Previtali, S., Marziali, S., Cortelazzo, S., Rossi, A., Barbui, T., & Galli, M. (2004) · The Hematology Journal · doi:10.1038/sj.thj.6200377 · Cited by 66
Self-citation
The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies
Nash, M. J., Camilleri, R. S., Kunka, S., Mackie, I. J., Machin, S. J., & Cohen, H. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00810.x · Cited by 64
Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder
D’Ippolito, S., Meroni, P. L., Koike, T., Veglia, M., Scambia, G., & Simone, N. D. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.05.004 · Cited by 64
Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study
Amengual, O., Forastiero, R. R., Sugiura‐Ogasawara, M., Otomo, K., Oku, K., Favas, C., Alves, J. D., Žigon, P., Ambrožič, A., Tomšič, M., et al. (2016) · Lupus · doi:10.1177/0961203316660203 · Cited by 63
Antiphospholipid syndrome
Khamashta, M. A., Taraborelli, M., Sciascia, S., & Tincani, A. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.04.002 · Cited by 66
Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?
Pregnolato, F., Chighizola, C. B., Encabo, S., Shums, Z., Norman, G. L., Tripodi, A., Chantarangkul, V., Bertero, T., Micheli, V. D., Borghi, M. O., et al. (2013) · Immunologic Research · doi:10.1007/s12026-013-8421-z · Cited by 61
Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study
Comellas-Kirkerup, L., Hernández‐Molina, G., & Cabral, A. R. (2010) · Blood · doi:10.1182/blood-2010-05-283507 · Cited by 61
The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature
Chighizola, C. B., Andréoli, L., de Jesús, G. R., Banzato, A., Pons‐Estel, G., & Erkan, D. (2015) · Lupus · doi:10.1177/0961203315572714 · Cited by 59
Variability of anti-β2 glycoprotein I antibodies measurement by commercial assays
Tincani, A., Sanmarco, M., de Moerloose, P., Boffa, M., & Reber, G. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-02-0081 · Cited by 59
Cofactor‐independent human antiphospholipid antibodies induce venous thrombosis in mice
Manukyan, D., Müller‐Calleja, N., Jäckel, S., Luchmann, K., Mönnikes, R., Kiouptsi, K., Reinhardt, C., Jurk, K., Walter, U., & Lackner, K. J. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13263 · Cited by 58
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – Yes
Brenner, B. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00504.x · Cited by 58
Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2′ and glycoprotein I bα
Zhang, W., Gao, F., Lu, D., Sun, N., Yin, X., Jin, M., & Liu, Y. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0426-7 · Cited by 56
Risk factors for arterial thrombosis in antiphospholipid syndrome
Matyja‐Bednarczyk, A., Swadźba, J., Iwaniec, T., Sanak, M., Dziedzina, S., Ćmiel, A., & Musiał, J. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.11.012 · Cited by 54
Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies
Chauleur, C., Galanaud, J. ‐., Alonso, S., Cochery-Nouvellon, É., Balducchi, J.-P., Marès, P., Fabbro-Péray, P., & Gris, J. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03747.x · Cited by 54
Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case–control study
Martínez‐Zamora, M. Á., Peralta, S., Creus, M. T., Tàssies, D., Reverter, J. C., Espinosa, G., Cervera, R., Carmona, F., & Balasch, J. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.153817 · Cited by 54
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review
Menichelli, D., Cormaci, V. M., Marucci, S., Franchino, G., Sole, F. D., Capozza, A., Fallarino, A., Valeriani, E., Violi, F., Pignatelli, P., et al. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103447 · Cited by 52
Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome
Fujieda, Y., Atsumi, T., Amengual, O., Odani, T., Otomo, K., Kato, M., Oku, K., Kon, Y., Horita, T., Yasuda, S., et al. (2012) · Lupus · doi:10.1177/0961203312458469 · Cited by 52
Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients
Ma, J., Song, H., Wei, M., & He, Y. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3776-5 · Cited by 51
Antiphospholipid antibodies: Lessons from the bench
Koike, T., Bohgaki, M., Amengual, O., & Atsumi, T. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.02.009 · Cited by 51
Obstetric and vascular APS: Same autoantibodies but different diseases?
Meroni, P. L., Raschi, E., Grossi, C., Pregnolato, F., Trespìdi, L., Acaia, B., & Borghi, M. O. (2012) · Lupus · doi:10.1177/0961203312438116 · Cited by 50
The Lupus Anticoagulant Paradox
Molhoek, J. E., de Groot, P. G., & Urbanus, R. T. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1606190 · Cited by 50
Annexin A2: biology and relevance to the antiphospholipid syndrome
Cockrell, E., Espinola, R., & McCrae, K. (2008) · Lupus · doi:10.1177/0961203308095329 · Cited by 50
High titer of serum antiphospholipid antibody levels in adult Henoch‐Schönlein purpura and cutaneous leukocytoclastic angiitis
Kawakami, T., Yamazaki, M., Mizoguchi, M., & Soma, Y. (2008) · Arthritis Care & Research · doi:10.1002/art.23528 · Cited by 50
The obstetric antiphospholipid syndrome
Derksen, R. H. W. M., & de Groot, P. G. (2007) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2006.12.003 · Cited by 50
Internal quality control and external quality assurance in testing for antiphospholipid antibodies: part II–lupus anticoagulant
Favaloro, E., Bonar, R., & Marsden, K. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0032-1311993 · Cited by 49
Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome: Molecular Mechanisms and Signaling through Lipid Rafts
Capozzi, A., Manganelli, V., Riitano, G., Caissutti, D., Longo, A., Garofalo, T., Sorice, M., & Misasi, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030891 · Cited by 49
An international multicentre‐laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti‐beta2‐glycoprotein autoantibodies
de Laat, B., Derksen, R. H. W. M., Reber, G., Musiał, J., Swadźba, J., Božič, B., Čučnik, S., Regnault, V., Forastiero, R. R., Woodhams, B. J., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04068.x · Cited by 49
Lupus nephritis and Raynaud’s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies
Choojitarom, K., Verasertniyom, O., Totemchokchyakarn, K., Nantiruj, K., Sumethkul, V., & Janwityanujit, S. (2007) · Clinical Rheumatology · doi:10.1007/s10067-007-0721-z · Cited by 49
Clinical laboratory testing for the antiphospholipid syndrome
Pierangeli, S. S., & Harris, E. N. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.02.002 · Cited by 49
Mannose-binding lectin-2 genotypes and recurrent late pregnancy losses
Christiansen, O. B., Nielsen, H. S., Lund, M., Steffensen, R., & Varming, K. (2008) · Human Reproduction · doi:10.1093/humrep/den377 · Cited by 48
Thrombophilia and Pregnancy
Kupferminc, M. J. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381855 · Cited by 47
Anti‐prothrombin IgG from patients with anti‐phospholipid antibodies inhibits the inactivation of factor Va by activated protein C
Galli, M., Willems, G. M., Rosing, J., Janssen, R. M., Govers‐Riemslag, J. W. P., Comfurius, P., Barbui, T., Zwaal, R. F. A., & Bevers, E. M. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05438.x · Cited by 47
Self-citation

Authors: Galli, M., Luciani, D., Bertolini, G., & Barbui, T.
Affiliations: From the Division of Hematology, Ospedali Riuniti, Bergamo, Italy; and the Laboratory of Clinical Epidemiology, Istituto “Mario Negri,” Ranica Bergamo (BG), Italy.
ORCID: Galli, Monica
Luciani, Davide
Bertolini, Guido
Barbui, Tiziano
Venue: Blood
Publisher: American Society of Hematology
Published: 2003-10-15
Volume: 102
Issue: 8
Pages: 2717-2723
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2002-11-3334
OpenAlex: W2069794594
Cited by: 413
References: 72
Citations by year: 2026: 4 · 2025: 4 · 2024: 8 · 2023: 9 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 11 · 2017: 13 · 2016: 16 · 2015: 20 · 2014: 17 · 2013: 27 · 2012: 26
FWCI: 4.16
Type: journal article
Language: en
Open access: closed
Locations: Blood (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
Keywords: antiphospholipid syndrome, anti-beta2-glycoprotein I antibodies, anti-prothrombin antibodies, lupus anticoagulant, thrombosis risk, thrombosis risk factors, pregnancy complications
MeSH terms: Antibodies, Cardiolipins, Female, Glycoproteins, Humans, Pregnancy, Pregnancy Complications, Hematologic, Prothrombin, Retrospective Studies, Thrombosis, Odds Ratio, Antiphospholipid Syndrome, beta 2-Glycoprotein I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks